Zhitong Finance App News, Tianjin Pharmaceutical (600488.SH) issued an announcement. Recently, the company's subsidiary Hubei Jinyao Pharmaceutical Co., Ltd. received the “Drug Registration Certificate” for bupivacaine hydrochloride injections approved and issued by the State Drug Administration. Bupivacaine hydrochloride injection is used for local infiltration anesthesia, peripheral nerve block, and intraspinal block.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.